首页 | 本学科首页   官方微博 | 高级检索  
检索        

噻托溴铵联合小剂量布地奈德福莫特罗治疗中重度支气管哮喘并慢性阻塞性肺疾病26例
引用本文:卢丽,闫庆红.噻托溴铵联合小剂量布地奈德福莫特罗治疗中重度支气管哮喘并慢性阻塞性肺疾病26例[J].中国药业,2011,20(21):72-73.
作者姓名:卢丽  闫庆红
作者单位:1. 山东省单县东大医院,山东菏泽,273000
2. 山东省单县中心医院,山东菏泽,273000
摘    要:目的 观察国产噻托溴铵联合布地奈德福莫特罗对中重度支气管哮喘并慢性阻塞性肺疾病(COPD)的疗效.方法 采用随机、双盲的方法将51例患者分为治疗组(26例)和对照组(25例).治疗组给予国产噻托溴铵联合小剂量布地奈德福莫特罗,对照组给予中等剂量布地奈德福莫特罗,治疗12个月.结果 与对照组比较,治疗组患者生活质量评分、急性发作次数差异有统计学意义(P<0.05),而第1秒用力呼气容积(FEV1)两组差异无统计学意义(P>0.05).结论 国产噻托溴铵联合小剂量布地奈德福莫特罗吸入治疗中重度支气管哮喘合并慢性阻塞性肺疾病,与单用中等剂量布地奈德福莫特罗相比,在改善患者生活质量、减少急性加重次数方面更有优越性.

关 键 词:噻托溴铵  布地奈德福莫特罗  支气管哮喘  慢性阻塞性肺疾病

Tiotropium Bromide Combined with Low Dose of Budesonide/Formoterol for Treating Moderate to Severe Bronchial Asthma Complicating COPD in 26 Cases
Lu Li,Yan Qinghong.Tiotropium Bromide Combined with Low Dose of Budesonide/Formoterol for Treating Moderate to Severe Bronchial Asthma Complicating COPD in 26 Cases[J].China Pharmaceuticals,2011,20(21):72-73.
Authors:Lu Li  Yan Qinghong
Institution:Lu Li1,Yan Qinghong2(1.Shanxian Dongda Hospital,Heze,Shandong,China 273000,2.Shanxian Central Hospital,China 273000)
Abstract:Objective To investigate the effects of tiotropium bromide combined with low dose of budesonide/formoterol on treating moderate to severe bronchial asthma complicating chronic obstructive pulmonary disease(COPD).Methods Fifty-one patients with moderate to severe bronchial asthma complicating COPD were randomized to two groups:group A(experiment group,26 cases) and group B(control group,25 cases).The group A was given homemade tiotropium bromide combined with low dose of budesonide/formoterol and the group B...
Keywords:tiotropium bromide  budesonide/formoterol  bronchial asthma  chronic obstructive pulmonary disease  
本文献已被 CNKI 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号